David Caldwell
Concepts (340)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chickens | 28 | 2012 | 118 | 3.300 |
Why?
| Education, Pharmacy | 11 | 2024 | 165 | 3.160 |
Why?
| Students, Pharmacy | 8 | 2019 | 147 | 1.530 |
Why?
| Educational Measurement | 6 | 2019 | 232 | 1.510 |
Why?
| Salmonella | 8 | 2012 | 25 | 1.370 |
Why?
| Meat | 8 | 2011 | 59 | 1.360 |
Why?
| Food Microbiology | 9 | 2011 | 48 | 1.340 |
Why?
| Poultry Diseases | 11 | 2011 | 28 | 1.220 |
Why?
| Food Contamination | 5 | 2012 | 42 | 0.940 |
Why?
| Motor Cortex | 2 | 2020 | 18 | 0.930 |
Why?
| Animal Feed | 4 | 2012 | 64 | 0.920 |
Why?
| Deep Brain Stimulation | 2 | 2020 | 48 | 0.900 |
Why?
| Trichothecenes | 2 | 2012 | 3 | 0.890 |
Why?
| Aflatoxins | 2 | 2012 | 13 | 0.880 |
Why?
| HIV Infections | 3 | 2012 | 393 | 0.820 |
Why?
| Reverse Transcriptase Inhibitors | 2 | 2012 | 6 | 0.790 |
Why?
| Faculty | 2 | 2024 | 84 | 0.750 |
Why?
| Program Evaluation | 3 | 2017 | 372 | 0.700 |
Why?
| Touch Perception | 1 | 2019 | 3 | 0.700 |
Why?
| Somatosensory Cortex | 1 | 2019 | 9 | 0.690 |
Why?
| Evoked Potentials, Somatosensory | 1 | 2019 | 12 | 0.690 |
Why?
| Touch | 1 | 2019 | 27 | 0.690 |
Why?
| Self-Assessment | 1 | 2019 | 50 | 0.680 |
Why?
| Writing | 2 | 2022 | 42 | 0.660 |
Why?
| Coccidiosis | 4 | 2011 | 8 | 0.660 |
Why?
| Reaction Time | 1 | 2019 | 227 | 0.640 |
Why?
| Diet | 2 | 2012 | 598 | 0.640 |
Why?
| Salmonella Infections, Animal | 9 | 2012 | 17 | 0.610 |
Why?
| Salmonella enteritidis | 6 | 2008 | 8 | 0.600 |
Why?
| Education, Distance | 1 | 2017 | 39 | 0.580 |
Why?
| Serum Albumin, Bovine | 3 | 2006 | 25 | 0.580 |
Why?
| Tissue Engineering | 3 | 2014 | 61 | 0.570 |
Why?
| Curriculum | 4 | 2019 | 426 | 0.560 |
Why?
| Chick Embryo | 3 | 2000 | 79 | 0.560 |
Why?
| Antibiotic Prophylaxis | 3 | 2000 | 67 | 0.560 |
Why?
| Pharmaceutical Services | 3 | 2022 | 57 | 0.560 |
Why?
| Peer Review | 1 | 2015 | 9 | 0.540 |
Why?
| Cooperative Behavior | 3 | 2017 | 253 | 0.520 |
Why?
| Animals | 38 | 2014 | 14384 | 0.510 |
Why?
| Peptides | 4 | 2003 | 276 | 0.510 |
Why?
| Antibodies | 2 | 2006 | 178 | 0.500 |
Why?
| Nitriles | 2 | 2012 | 69 | 0.490 |
Why?
| Self Care | 1 | 2015 | 147 | 0.490 |
Why?
| Eimeria | 2 | 2011 | 3 | 0.480 |
Why?
| Electrophoresis, Gel, Two-Dimensional | 2 | 2010 | 55 | 0.470 |
Why?
| Test Taking Skills | 1 | 2013 | 9 | 0.460 |
Why?
| Campylobacter | 2 | 2011 | 4 | 0.460 |
Why?
| Pyrimidines | 2 | 2012 | 196 | 0.450 |
Why?
| Biomimetic Materials | 1 | 2012 | 11 | 0.450 |
Why?
| Intestinal Mucosa | 3 | 2004 | 259 | 0.440 |
Why?
| Drug Residues | 3 | 2000 | 9 | 0.440 |
Why?
| Chitosan | 1 | 2012 | 34 | 0.440 |
Why?
| Biocompatible Materials | 1 | 2012 | 65 | 0.430 |
Why?
| HIV Integrase Inhibitors | 1 | 2012 | 2 | 0.420 |
Why?
| Collagen Type I | 1 | 2012 | 97 | 0.420 |
Why?
| Protozoan Vaccines | 1 | 2011 | 1 | 0.410 |
Why?
| Food Packaging | 1 | 2011 | 7 | 0.410 |
Why?
| Quinolones | 1 | 2012 | 35 | 0.400 |
Why?
| Humans | 28 | 2024 | 54205 | 0.400 |
Why?
| Pharmacy | 2 | 2022 | 64 | 0.400 |
Why?
| Fibroblasts | 1 | 2012 | 386 | 0.370 |
Why?
| Pyridazines | 1 | 2010 | 12 | 0.370 |
Why?
| Poultry | 2 | 2004 | 29 | 0.370 |
Why?
| Anti-HIV Agents | 1 | 2010 | 43 | 0.360 |
Why?
| Cyclohexanes | 1 | 2008 | 2 | 0.340 |
Why?
| Dietary Proteins | 1 | 2011 | 230 | 0.330 |
Why?
| Polymerase Chain Reaction | 1 | 2010 | 531 | 0.330 |
Why?
| Bursa of Fabricius | 4 | 2003 | 6 | 0.330 |
Why?
| Triazoles | 1 | 2008 | 120 | 0.320 |
Why?
| Drug Administration Schedule | 3 | 2012 | 400 | 0.300 |
Why?
| Mast Cells | 2 | 2004 | 64 | 0.300 |
Why?
| Housing, Animal | 2 | 1998 | 16 | 0.300 |
Why?
| Oligodeoxyribonucleotides | 1 | 2006 | 30 | 0.280 |
Why?
| Cecum | 7 | 2011 | 72 | 0.280 |
Why?
| Turkeys | 4 | 2011 | 11 | 0.270 |
Why?
| Immunity, Mucosal | 2 | 2004 | 19 | 0.260 |
Why?
| Water | 2 | 2004 | 102 | 0.250 |
Why?
| Antigens | 1 | 2004 | 53 | 0.250 |
Why?
| Anaphylaxis | 2 | 2004 | 71 | 0.250 |
Why?
| Learning | 2 | 2024 | 171 | 0.240 |
Why?
| Female | 11 | 2024 | 28410 | 0.240 |
Why?
| Immunoglobulin G | 4 | 2006 | 226 | 0.230 |
Why?
| Male | 11 | 2024 | 27311 | 0.230 |
Why?
| Mitogens | 2 | 1999 | 16 | 0.220 |
Why?
| Pilot Projects | 3 | 2022 | 807 | 0.220 |
Why?
| Teaching | 1 | 2024 | 125 | 0.220 |
Why?
| B-Lymphocytes | 2 | 2003 | 176 | 0.220 |
Why?
| Communication | 2 | 2022 | 265 | 0.210 |
Why?
| Crop, Avian | 6 | 2008 | 7 | 0.210 |
Why?
| Job Application | 1 | 2021 | 12 | 0.210 |
Why?
| Students | 1 | 2024 | 207 | 0.210 |
Why?
| Neurosurgery | 1 | 2021 | 34 | 0.200 |
Why?
| Clinical Trials, Phase IV as Topic | 1 | 2021 | 1 | 0.200 |
Why?
| Drug Resistance, Viral | 2 | 2012 | 8 | 0.200 |
Why?
| National Library of Medicine (U.S.) | 1 | 2021 | 4 | 0.200 |
Why?
| Control Groups | 1 | 2021 | 10 | 0.200 |
Why?
| Egg Yolk | 1 | 2000 | 2 | 0.200 |
Why?
| Heat Stress Disorders | 1 | 2001 | 19 | 0.200 |
Why?
| Yolk Sac | 1 | 2000 | 10 | 0.200 |
Why?
| Clinical Trials, Phase III as Topic | 1 | 2021 | 48 | 0.200 |
Why?
| Immunity, Cellular | 1 | 2001 | 80 | 0.190 |
Why?
| Gentamicins | 1 | 2000 | 36 | 0.190 |
Why?
| Subthalamic Nucleus | 1 | 2020 | 13 | 0.190 |
Why?
| Cephalosporins | 1 | 2000 | 32 | 0.190 |
Why?
| Faculty, Medical | 1 | 2021 | 100 | 0.190 |
Why?
| Cells, Cultured | 6 | 2014 | 1737 | 0.190 |
Why?
| Interferon-gamma | 1 | 2001 | 195 | 0.180 |
Why?
| Electric Stimulation | 1 | 2020 | 95 | 0.180 |
Why?
| Eimeria tenella | 2 | 2011 | 5 | 0.180 |
Why?
| Artifacts | 1 | 2020 | 61 | 0.180 |
Why?
| United States | 8 | 2022 | 5196 | 0.180 |
Why?
| Phylogeny | 2 | 2010 | 269 | 0.170 |
Why?
| Program Development | 2 | 2017 | 198 | 0.170 |
Why?
| Drug Therapy, Combination | 2 | 2012 | 426 | 0.170 |
Why?
| Prolactin | 1 | 1999 | 43 | 0.170 |
Why?
| Pituitary Gland, Anterior | 1 | 1999 | 28 | 0.170 |
Why?
| Time Factors | 8 | 2014 | 3209 | 0.170 |
Why?
| Perception | 1 | 2019 | 142 | 0.170 |
Why?
| Dietary Supplements | 2 | 2012 | 449 | 0.170 |
Why?
| Administration, Oral | 3 | 2006 | 459 | 0.160 |
Why?
| Growth Hormone | 1 | 1999 | 78 | 0.160 |
Why?
| Environmental Microbiology | 1 | 1998 | 7 | 0.160 |
Why?
| DNA Replication | 1 | 1999 | 152 | 0.160 |
Why?
| Cardiovascular Diseases | 2 | 2021 | 476 | 0.160 |
Why?
| Protective Clothing | 1 | 1998 | 8 | 0.160 |
Why?
| Staff Development | 1 | 2017 | 26 | 0.160 |
Why?
| Leukocytes, Mononuclear | 1 | 1998 | 133 | 0.160 |
Why?
| Parkinson Disease | 1 | 2020 | 180 | 0.160 |
Why?
| Bacteriological Techniques | 2 | 1995 | 38 | 0.160 |
Why?
| Clinical Trials as Topic | 1 | 2020 | 490 | 0.160 |
Why?
| Databases, Factual | 1 | 2021 | 683 | 0.160 |
Why?
| Blood Pressure | 1 | 2020 | 587 | 0.160 |
Why?
| Achievement | 1 | 2017 | 46 | 0.150 |
Why?
| Healthcare Disparities | 1 | 2020 | 269 | 0.150 |
Why?
| Professional Role | 1 | 2017 | 88 | 0.150 |
Why?
| Leadership | 1 | 2017 | 114 | 0.150 |
Why?
| Disinfectants | 2 | 2011 | 12 | 0.140 |
Why?
| Random Allocation | 5 | 2008 | 312 | 0.140 |
Why?
| Food Deprivation | 5 | 2008 | 29 | 0.140 |
Why?
| Animal Husbandry | 2 | 1999 | 12 | 0.140 |
Why?
| Internship and Residency | 1 | 2021 | 495 | 0.130 |
Why?
| Hypertension | 1 | 2020 | 564 | 0.130 |
Why?
| Serotyping | 2 | 2010 | 15 | 0.130 |
Why?
| Longitudinal Studies | 1 | 2017 | 740 | 0.130 |
Why?
| Osteogenesis | 2 | 2014 | 377 | 0.130 |
Why?
| Retrospective Studies | 2 | 2024 | 6429 | 0.120 |
Why?
| Neovascularization, Physiologic | 1 | 2014 | 72 | 0.120 |
Why?
| Bone Development | 1 | 2014 | 69 | 0.120 |
Why?
| Cell Differentiation | 2 | 2014 | 720 | 0.120 |
Why?
| Cell Survival | 2 | 2014 | 657 | 0.120 |
Why?
| Discriminant Analysis | 1 | 2013 | 34 | 0.120 |
Why?
| Intestines | 2 | 2006 | 204 | 0.120 |
Why?
| Community-Institutional Relations | 1 | 2013 | 51 | 0.110 |
Why?
| Task Performance and Analysis | 1 | 2013 | 61 | 0.110 |
Why?
| Medically Underserved Area | 1 | 2013 | 45 | 0.110 |
Why?
| Injections, Intraperitoneal | 2 | 2004 | 59 | 0.110 |
Why?
| Adult | 5 | 2022 | 14191 | 0.110 |
Why?
| Gene Transfer, Horizontal | 1 | 2012 | 7 | 0.110 |
Why?
| Egg Shell | 1 | 2012 | 1 | 0.110 |
Why?
| Cellular Microenvironment | 1 | 2012 | 27 | 0.110 |
Why?
| Materials Testing | 1 | 2012 | 62 | 0.110 |
Why?
| Immunization | 2 | 2004 | 95 | 0.110 |
Why?
| Guidelines as Topic | 1 | 2013 | 125 | 0.110 |
Why?
| Endothelial Cells | 1 | 2014 | 294 | 0.110 |
Why?
| Drug Resistance, Bacterial | 1 | 2012 | 81 | 0.110 |
Why?
| Extracellular Matrix | 1 | 2012 | 111 | 0.110 |
Why?
| Psychometrics | 1 | 2013 | 239 | 0.100 |
Why?
| Educational Status | 1 | 2013 | 260 | 0.100 |
Why?
| Cell Proliferation | 2 | 2014 | 1096 | 0.100 |
Why?
| Community Pharmacy Services | 1 | 2013 | 70 | 0.100 |
Why?
| Guideline Adherence | 1 | 2013 | 148 | 0.100 |
Why?
| Cell Division | 3 | 2003 | 330 | 0.100 |
Why?
| Spleen | 1 | 2012 | 186 | 0.100 |
Why?
| Brain | 1 | 2020 | 1387 | 0.100 |
Why?
| Roxarsone | 1 | 2011 | 1 | 0.100 |
Why?
| Steroids | 2 | 2003 | 53 | 0.100 |
Why?
| Salmonella enterica | 1 | 2011 | 18 | 0.100 |
Why?
| Injections, Subcutaneous | 2 | 2001 | 58 | 0.100 |
Why?
| Drug Resistance, Microbial | 2 | 2000 | 51 | 0.100 |
Why?
| Abattoirs | 1 | 2010 | 11 | 0.100 |
Why?
| Feces | 1 | 2011 | 135 | 0.090 |
Why?
| Escherichia coli | 1 | 2012 | 250 | 0.090 |
Why?
| Osteoblasts | 1 | 2014 | 514 | 0.090 |
Why?
| Weight Gain | 1 | 2011 | 244 | 0.090 |
Why?
| DNA, Bacterial | 1 | 2010 | 172 | 0.090 |
Why?
| HIV Fusion Inhibitors | 1 | 2008 | 3 | 0.090 |
Why?
| Anti-Retroviral Agents | 1 | 2008 | 18 | 0.090 |
Why?
| Drinking | 3 | 2004 | 78 | 0.080 |
Why?
| Molting | 1 | 2008 | 1 | 0.080 |
Why?
| Cyamopsis | 1 | 2008 | 1 | 0.080 |
Why?
| Liver | 2 | 2012 | 1225 | 0.080 |
Why?
| Immunoglobulin Variable Region | 1 | 2007 | 33 | 0.080 |
Why?
| Antibodies, Protozoan | 1 | 2007 | 12 | 0.080 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2007 | 314 | 0.080 |
Why?
| Virus Replication | 1 | 2008 | 143 | 0.080 |
Why?
| Transportation | 1 | 2007 | 31 | 0.070 |
Why?
| Kidney | 1 | 2012 | 820 | 0.070 |
Why?
| Sheep | 1 | 2007 | 88 | 0.070 |
Why?
| Antibody Formation | 1 | 2007 | 69 | 0.070 |
Why?
| Immunoglobulin A | 1 | 2006 | 54 | 0.070 |
Why?
| Immunoglobulin M | 1 | 2006 | 65 | 0.070 |
Why?
| Disease Susceptibility | 2 | 2008 | 95 | 0.070 |
Why?
| Adjuvants, Immunologic | 1 | 2006 | 61 | 0.070 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2008 | 596 | 0.070 |
Why?
| Stress, Physiological | 1 | 2007 | 194 | 0.070 |
Why?
| Bile | 1 | 2004 | 24 | 0.060 |
Why?
| Schools, Pharmacy | 2 | 2017 | 68 | 0.060 |
Why?
| Immunoglobulin A, Secretory | 1 | 2004 | 9 | 0.060 |
Why?
| Anti-Bacterial Agents | 1 | 2011 | 820 | 0.060 |
Why?
| Dose-Response Relationship, Drug | 1 | 2006 | 1476 | 0.050 |
Why?
| Online Systems | 1 | 2021 | 9 | 0.050 |
Why?
| Universities | 1 | 2022 | 164 | 0.050 |
Why?
| Oviposition | 1 | 2001 | 11 | 0.050 |
Why?
| Dose-Response Relationship, Immunologic | 1 | 2001 | 16 | 0.050 |
Why?
| Colony Count, Microbial | 1 | 2001 | 66 | 0.050 |
Why?
| Electrophysiology | 1 | 2001 | 76 | 0.050 |
Why?
| Salmonella typhimurium | 1 | 2001 | 54 | 0.050 |
Why?
| Gastrointestinal Contents | 1 | 2000 | 2 | 0.050 |
Why?
| Bacillus cereus | 1 | 2000 | 7 | 0.050 |
Why?
| Hospitals | 1 | 2022 | 188 | 0.050 |
Why?
| Fatty Acids, Volatile | 1 | 2000 | 12 | 0.050 |
Why?
| Chlorides | 1 | 2001 | 58 | 0.050 |
Why?
| Case-Control Studies | 2 | 2001 | 1228 | 0.050 |
Why?
| Klebsiella pneumoniae | 1 | 2000 | 23 | 0.050 |
Why?
| Biological Transport | 1 | 2001 | 195 | 0.050 |
Why?
| Seasons | 1 | 2001 | 98 | 0.050 |
Why?
| Pharmacists | 1 | 2022 | 152 | 0.050 |
Why?
| Lactic Acid | 1 | 2001 | 90 | 0.050 |
Why?
| Glucocorticoids | 1 | 2002 | 234 | 0.050 |
Why?
| Diffusion Tensor Imaging | 1 | 2020 | 97 | 0.050 |
Why?
| Phorbol 12,13-Dibutyrate | 1 | 1999 | 2 | 0.040 |
Why?
| Prevalence | 2 | 2020 | 1024 | 0.040 |
Why?
| Lactose | 1 | 1999 | 10 | 0.040 |
Why?
| Recombinant Proteins | 1 | 2001 | 569 | 0.040 |
Why?
| Hemolytic Plaque Technique | 1 | 1999 | 3 | 0.040 |
Why?
| Vasoactive Intestinal Peptide | 1 | 1999 | 18 | 0.040 |
Why?
| Disinfection | 1 | 1999 | 12 | 0.040 |
Why?
| Length of Stay | 1 | 2022 | 683 | 0.040 |
Why?
| DNA | 2 | 2003 | 581 | 0.040 |
Why?
| Phytohemagglutinins | 1 | 1998 | 12 | 0.040 |
Why?
| Sensitivity and Specificity | 1 | 2000 | 922 | 0.040 |
Why?
| Analysis of Variance | 1 | 2019 | 634 | 0.040 |
Why?
| Financing, Organized | 1 | 2017 | 14 | 0.040 |
Why?
| Work | 1 | 2017 | 11 | 0.040 |
Why?
| Hospitalization | 1 | 2022 | 704 | 0.040 |
Why?
| Treatment Outcome | 1 | 2008 | 5604 | 0.040 |
Why?
| Motivation | 1 | 2019 | 289 | 0.040 |
Why?
| Publishing | 1 | 2017 | 45 | 0.040 |
Why?
| Research | 1 | 2017 | 110 | 0.040 |
Why?
| Apoptosis | 1 | 2002 | 1300 | 0.030 |
Why?
| Environmental Monitoring | 1 | 1995 | 71 | 0.030 |
Why?
| Mesenchymal Stem Cell Transplantation | 1 | 2014 | 19 | 0.030 |
Why?
| Evaluation Studies as Topic | 1 | 1994 | 107 | 0.030 |
Why?
| Coculture Techniques | 1 | 2014 | 160 | 0.030 |
Why?
| Cell Communication | 1 | 2014 | 72 | 0.030 |
Why?
| 3T3 Cells | 1 | 2014 | 52 | 0.030 |
Why?
| Cell Size | 1 | 2014 | 45 | 0.030 |
Why?
| Drug Therapy | 1 | 2013 | 50 | 0.030 |
Why?
| Haiti | 1 | 2013 | 4 | 0.030 |
Why?
| Louisiana | 1 | 2013 | 58 | 0.030 |
Why?
| Cell Culture Techniques | 1 | 2014 | 112 | 0.030 |
Why?
| Thinking | 1 | 2013 | 21 | 0.030 |
Why?
| Travel | 1 | 2013 | 30 | 0.030 |
Why?
| Professional-Patient Relations | 1 | 2013 | 52 | 0.030 |
Why?
| Escherichia coli Infections | 1 | 2012 | 33 | 0.030 |
Why?
| Personal Satisfaction | 1 | 2013 | 90 | 0.030 |
Why?
| Collagen | 1 | 2014 | 223 | 0.030 |
Why?
| Cattle | 1 | 2012 | 224 | 0.030 |
Why?
| Ultrasonography | 1 | 2014 | 480 | 0.030 |
Why?
| Calcium | 1 | 2014 | 432 | 0.030 |
Why?
| Oocysts | 1 | 2011 | 2 | 0.030 |
Why?
| Rats | 1 | 1998 | 3415 | 0.030 |
Why?
| Patient Care Team | 1 | 2013 | 273 | 0.020 |
Why?
| Gastrointestinal Tract | 1 | 2012 | 135 | 0.020 |
Why?
| Meat-Packing Industry | 1 | 2011 | 8 | 0.020 |
Why?
| Predictive Value of Tests | 1 | 1994 | 1045 | 0.020 |
Why?
| Drug Resistance, Multiple, Bacterial | 1 | 2011 | 60 | 0.020 |
Why?
| Health Promotion | 1 | 2013 | 300 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2014 | 1301 | 0.020 |
Why?
| Microbial Sensitivity Tests | 1 | 2011 | 290 | 0.020 |
Why?
| Clinical Competence | 1 | 2013 | 442 | 0.020 |
Why?
| Attitude of Health Personnel | 1 | 2013 | 390 | 0.020 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 541 | 0.020 |
Why?
| Photoperiod | 1 | 2008 | 6 | 0.020 |
Why?
| Bacterial Translocation | 1 | 2008 | 23 | 0.020 |
Why?
| Antibody Specificity | 1 | 2007 | 48 | 0.020 |
Why?
| Peptide Library | 1 | 2007 | 29 | 0.020 |
Why?
| Ovary | 1 | 2008 | 105 | 0.020 |
Why?
| Organ Size | 1 | 2008 | 237 | 0.020 |
Why?
| Ovalbumin | 1 | 2007 | 17 | 0.020 |
Why?
| Sequence Alignment | 1 | 2007 | 146 | 0.020 |
Why?
| Animal Welfare | 1 | 2007 | 9 | 0.020 |
Why?
| Blood Urea Nitrogen | 1 | 2007 | 51 | 0.020 |
Why?
| Middle Aged | 1 | 2022 | 13072 | 0.020 |
Why?
| Bilirubin | 1 | 2007 | 49 | 0.020 |
Why?
| Disease Models, Animal | 1 | 2012 | 1639 | 0.020 |
Why?
| Creatinine | 1 | 2007 | 169 | 0.020 |
Why?
| Hydrocortisone | 1 | 2007 | 124 | 0.020 |
Why?
| Rest | 1 | 2007 | 68 | 0.020 |
Why?
| Microscopy, Fluorescence | 1 | 2007 | 198 | 0.020 |
Why?
| Base Sequence | 1 | 2007 | 719 | 0.020 |
Why?
| Amino Acid Sequence | 1 | 2007 | 767 | 0.020 |
Why?
| Molecular Sequence Data | 1 | 2007 | 980 | 0.020 |
Why?
| Vaccination | 1 | 2007 | 294 | 0.020 |
Why?
| Body Weight | 1 | 2007 | 578 | 0.020 |
Why?
| Blood Glucose | 1 | 2007 | 489 | 0.010 |
Why?
| Phorbols | 1 | 2003 | 2 | 0.010 |
Why?
| Immunoglobulin Fc Fragments | 1 | 2003 | 12 | 0.010 |
Why?
| Immunoglobulin Fab Fragments | 1 | 2003 | 21 | 0.010 |
Why?
| Nandrolone | 1 | 2002 | 2 | 0.010 |
Why?
| Lymphocyte Count | 1 | 2002 | 23 | 0.010 |
Why?
| Mice | 1 | 2014 | 6413 | 0.010 |
Why?
| Epithelium | 1 | 2002 | 68 | 0.010 |
Why?
| In Situ Nick-End Labeling | 1 | 2002 | 64 | 0.010 |
Why?
| Proliferating Cell Nuclear Antigen | 1 | 2002 | 82 | 0.010 |
Why?
| Fluorescein | 1 | 2002 | 9 | 0.010 |
Why?
| Food-Processing Industry | 1 | 2002 | 11 | 0.010 |
Why?
| Rabbits | 1 | 2003 | 425 | 0.010 |
Why?
| Animals, Newborn | 1 | 2003 | 396 | 0.010 |
Why?
| Campylobacter Infections | 1 | 2001 | 8 | 0.010 |
Why?
| Fluorescent Dyes | 1 | 2002 | 116 | 0.010 |
Why?
| Hydrogen-Ion Concentration | 1 | 2001 | 194 | 0.010 |
Why?
| Dexamethasone | 1 | 2002 | 435 | 0.010 |
Why?
| Potassium Iodide | 1 | 1999 | 1 | 0.010 |
Why?
| Cyclohexenes | 1 | 1999 | 1 | 0.010 |
Why?
| Immunohistochemistry | 1 | 2002 | 1089 | 0.010 |
Why?
| Terpenes | 1 | 1999 | 16 | 0.010 |
Why?
| Acetic Acid | 1 | 1999 | 12 | 0.010 |
Why?
| Citric Acid | 1 | 1999 | 21 | 0.010 |
Why?
| Hippurates | 1 | 1999 | 10 | 0.010 |
Why?
| Iodine | 1 | 1999 | 12 | 0.010 |
Why?
| Chlorhexidine | 1 | 1999 | 11 | 0.010 |
Why?
| Drug Synergism | 1 | 1999 | 171 | 0.010 |
Why?
| Quality Control | 1 | 1998 | 101 | 0.010 |
Why?
| Specimen Handling | 1 | 1998 | 62 | 0.010 |
Why?
| Ethanol | 1 | 1999 | 322 | 0.010 |
Why?
| Propionates | 1 | 1995 | 28 | 0.010 |
Why?
| Skin | 1 | 1998 | 469 | 0.010 |
Why?
| Incidence | 1 | 1997 | 1082 | 0.010 |
Why?
| Muscle, Skeletal | 1 | 1998 | 846 | 0.010 |
Why?
|
|
Caldwell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|